Curative Health Insurance Secures $150M Series B for National Expansion

Curative Health Insurance Company has raised over $150 million in a Series B funding round, boosting its valuation to $1.25 billion. This influx of capital is set to support the company's national expansion efforts, particularly focusing on the mid-Atlantic states, building on its established presence in Texas, Florida, and Georgia. The funding round was led by TED chairman Chris Anderson's Upside Vision Fund, with significant contributions from Justin Mateen's JAM Fund, as well as investors like Mike Novogratz and Stanley Druckenmiller's Duquesne Family Office. The capital will also strengthen the company’s reserves to meet state regulatory requirements and uphold long-term financial strength ratings. Curative’s innovative $0-out-of-pocket health plan emphasizes a seamless member experience powered by AI, which combines data and human expertise to improve health outcomes and reduce costs. The insurance model requires members to complete an annual preventative health appointment, known as the Baseline Visit, to avoid out-of-pocket expenses. Since launching fewer than three years ago, Curative has grown to serve over 1,200 employer clients and more than 165,000 members. The company's data showcases positive impacts including increased primary care utilization by 20%, a 30% drop in hospital admissions, and up to 40% lower medication costs within the first year of plan adoption. Investments from this funding round will be directed at enhancing operational capabilities with AI, expanding network development, modernizing payment methods, and optimizing member engagement strategies. CEO Fred Turner highlights the company’s focus on eliminating financial barriers and improving health outcomes through a disruptive, technology-driven insurance model that integrates real human support and aligns incentives across stakeholders.